Article Figures & Data
Additional Files
Supplementary Data
- Supplementary Materials - Supplemental Text
- Table 1 - Data table
- Supplementary Table 2 - Study data
This OnlineFirst version was published on December 30, 2020
doi: 10.1158/1078-0432.CCR-20-2500
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Jump to section
Advertisement